Article | September 3, 2021

Designing Agile Manufacturing With An Integrated Drug Substance/Drug Product Ecosystem

Source: Cytiva
Cytiva

New therapies are emerging across the pharmaceutical landscape, due to a convergence of scientific discoveries and innovative technologies. While these therapies bring new hope to patient care, they also add challenges to a complex path to market.

Unpredictable timelines, high drug attrition rates, and decision-making that is in constant instability are all factors that threaten the ability to bring a therapy to market. Flexibility in development and manufacturing is a key factor in establishing operations that can respond to these variables and changing market conditions while also increasing efficiency.

Small and emerging companies that want to accelerate their biomanufacturing operations and protect their resources must find technologies and solutions to complete their workflow safely and efficiently – from idea to injection.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: